Aerska
Aerska is a biotechnology company that is creating RNA medications to treat, delay, and prevent brain disorders.
$39M Series A ·
Led by age1 · Source: fundraisingfox.com
Total raised: $60M across 2 sourced rounds
All 3 rounds ↓Signals
Aerska | 70 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
- X account created
- Series A · $39MSource: fundraisingfox.com
- Seed · $21M
Aage1 (lead),
BBACKED VC (lead),
SSpeedinvest (lead),
AAda Ventures,
BBlueYard Capital,
KKerna Ventures,
LLingotto,
NNorrsken Foundation,
PPsyMed Ventures,
SSaras Capital
Source: The Irish Times - Website created
- 2025
EEntrepreneur First · batchSource: joinef.com
Founders and team
DH
David Hardwicke FounderJO
Jack O'Meara CofounderSM
Stuart Milstein Founder
Investors
AAda Ventures
Aage1lead investor
BBACKED VClead investor
BBlueYard Capital
EEntrepreneur FirstacceleratorIIaso Ventures
KKerna Ventures
LLingotto
LLSP Dementia Fundlead investor
NNorrsken Foundation
PPsyMed Ventures
SSaras Capital
SSpeedinvestlead investor
Companies like Aerska
AAstrocyte Pharmaceuticals$9.5M Series B+ · Sep 2026
NNeurosoft BioelectronicsSeed · May 2026
IIntrinsic Medicine (fka Lupa Bio)
IInnornaSeries B+ · Apr 2022ZZag BioSeries A
RRisa Labs$11.1M Series A · Jan 2026
Other companies backed by age1
LLoyalSeries B+ · Mar 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/aerska (get a free API key).